BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 34117361)

  • 1. COL11A1 activates cancer-associated fibroblasts by modulating TGF-β3 through the NF-κB/IGFBP2 axis in ovarian cancer cells.
    Wu YH; Huang YF; Chang TH; Chen CC; Wu PY; Huang SC; Chou CY
    Oncogene; 2021 Jul; 40(26):4503-4519. PubMed ID: 34117361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of TWIST1 by COL11A1 promotes chemoresistance and inhibits apoptosis in ovarian cancer cells by modulating NF-κB-mediated IKKβ expression.
    Wu YH; Huang YF; Chang TH; Chou CY
    Int J Cancer; 2017 Dec; 141(11):2305-2317. PubMed ID: 28815582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COL11A1 promotes tumor progression and predicts poor clinical outcome in ovarian cancer.
    Wu YH; Chang TH; Huang YF; Huang HD; Chou CY
    Oncogene; 2014 Jun; 33(26):3432-40. PubMed ID: 23934190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periostin promotes ovarian cancer metastasis by enhancing M2 macrophages and cancer-associated fibroblasts via integrin-mediated NF-κB and TGF-β2 signaling.
    Lin SC; Liao YC; Chen PM; Yang YY; Wang YH; Tung SL; Chuang CM; Sung YW; Jang TH; Chuang SE; Wang LH
    J Biomed Sci; 2022 Dec; 29(1):109. PubMed ID: 36550569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COL11A1-driven positive feedback loop modulates fibroblast transformation and activates pancreatic cancer progression.
    Sun D; Dai T; Ji Y; Shen W; Bian W
    Cell Biol Int; 2023 Jun; 47(6):1081-1091. PubMed ID: 36861686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-β modulates ovarian cancer invasion by upregulating CAF-derived versican in the tumor microenvironment.
    Yeung TL; Leung CS; Wong KK; Samimi G; Thompson MS; Liu J; Zaid TM; Ghosh S; Birrer MJ; Mok SC
    Cancer Res; 2013 Aug; 73(16):5016-28. PubMed ID: 23824740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bruceine D suppresses CAF-promoted TNBC metastasis under TNF-α stimulation by inhibiting Notch1-Jagged1/NF-κB(p65) signaling.
    Chen H; Han X; Zhang Y; Wang K; Liu D; Hu Z; Wang J
    Phytomedicine; 2024 Jan; 123():154928. PubMed ID: 38043386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The downregulation of miR-509-3p expression by collagen type XI alpha 1-regulated hypermethylation facilitates cancer progression and chemoresistance via the DNA methyltransferase 1/Small ubiquitin-like modifier-3 axis in ovarian cancer cells.
    Wu YH; Huang YF; Wu PY; Chang TH; Huang SC; Chou CY
    J Ovarian Res; 2023 Jun; 16(1):124. PubMed ID: 37386587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitor of apoptosis proteins (IAPs) mediate collagen type XI alpha 1-driven cisplatin resistance in ovarian cancer.
    Rada M; Nallanthighal S; Cha J; Ryan K; Sage J; Eldred C; Ullo M; Orsulic S; Cheon DJ
    Oncogene; 2018 Aug; 37(35):4809-4820. PubMed ID: 29769618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An integrated analysis identifies STAT4 as a key regulator of ovarian cancer metastasis.
    Zhao L; Ji G; Le X; Luo Z; Wang C; Feng M; Xu L; Zhang Y; Lau WB; Lau B; Yang Y; Lei L; Yang H; Xuan Y; Chen Y; Deng X; Yi T; Yao S; Zhao X; Wei Y; Zhou S
    Oncogene; 2017 Jun; 36(24):3384-3396. PubMed ID: 28114283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical analysis of the expression of cancer-associated fibroblast markers in esophageal cancer with and without neoadjuvant therapy.
    Galván JA; Wiprächtiger J; Slotta-Huspenina J; Feith M; Ott K; Kröll D; Seiler CA; Langer R
    Virchows Arch; 2020 May; 476(5):725-734. PubMed ID: 31828432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collagen XI Alpha 1 (COL11A1) Expression in the Tumor Microenvironment Drives Neuroblastoma Dissemination.
    Truong DQ; Ho BT; Chau GC; Truong DK; Pham TTT; Nakagawara A; Bui CB
    Pediatr Dev Pathol; 2022; 25(2):91-98. PubMed ID: 34460335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of SLC7A1 in high-grade serous ovarian cancer promotes tumor progression and is involved in MAPK/ERK pathway and EMT.
    You S; Han X; Xu Y; Sui L; Song K; Yao Q
    Cancer Med; 2024 May; 13(10):e7217. PubMed ID: 38752472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stromal POSTN induced by TGF-β1 facilitates the migration and invasion of ovarian cancer.
    Yue H; Li W; Chen R; Wang J; Lu X; Li J
    Gynecol Oncol; 2021 Feb; 160(2):530-538. PubMed ID: 33317907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Akt inhibitor SC66 promotes cell sensitivity to cisplatin in chemoresistant ovarian cancer cells through inhibition of COL11A1 expression.
    Wu YH; Huang YF; Chen CC; Chou CY
    Cell Death Dis; 2019 Apr; 10(4):322. PubMed ID: 30975980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pan-cancer analyses and molecular subtypes based on the cancer-associated fibroblast landscape and tumor microenvironment infiltration characterization reveal clinical outcome and immunotherapy response in epithelial ovarian cancer.
    Zou R; Jiang Q; Jin T; Chen M; Yao L; Ding H
    Front Immunol; 2022; 13():956224. PubMed ID: 36032075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic Identification of Druggable Epithelial-Stromal Crosstalk Signaling Networks in Ovarian Cancer.
    Yeung TL; Sheng J; Leung CS; Li F; Kim J; Ho SY; Matzuk MM; Lu KH; Wong STC; Mok SC
    J Natl Cancer Inst; 2019 Mar; 111(3):272-282. PubMed ID: 29860390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRMP2 derived from cancer associated fibroblasts facilitates progression of ovarian cancer via HIF-1α-glycolysis signaling pathway.
    Jin Y; Bian S; Wang H; Mo J; Fei H; Li L; Chen T; Jiang H
    Cell Death Dis; 2022 Aug; 13(8):675. PubMed ID: 35927239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-beta1, transforming growth factor-beta2, and transforming growth factor-beta3 enhance ovarian cancer metastatic potential by inducing a Smad3-dependent epithelial-to-mesenchymal transition.
    Do TV; Kubba LA; Du H; Sturgis CD; Woodruff TK
    Mol Cancer Res; 2008 May; 6(5):695-705. PubMed ID: 18505915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A COL11A1-correlated pan-cancer gene signature of activated fibroblasts for the prioritization of therapeutic targets.
    Jia D; Liu Z; Deng N; Tan TZ; Huang RY; Taylor-Harding B; Cheon DJ; Lawrenson K; Wiedemeyer WR; Walts AE; Karlan BY; Orsulic S
    Cancer Lett; 2016 Nov; 382(2):203-214. PubMed ID: 27609069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.